Bone Marrow Transplant in Turkey

Which Types of Bone Marrow Transplant Are Used in Turkey?

Transplant type depends on the disease, treatment objective, donor availability, HLA compatibility, and the patient's individual clinical condition.

• Autologous HSCT: Doctors collect and later return the patient's own blood-forming stem cells.

• Matched-related HSCT: A suitably HLA-matched family member provides cells for an allogeneic transplant.

• Unrelated-donor HSCT: Donor registries can help locate compatible donors outside the patient's family.

• Haploidentical HSCT: A partially matched relative can provide cells under selected transplant protocols.

• Cord blood HSCT: Stored umbilical cord blood can provide another allogeneic stem cell source.

Turkish public transplant centers document autologous, unrelated, haploidentical, and cord blood pathways.

How Do HLA Matching and TÜRKÖK Donor Searches Work in Turkey?

HLA matching helps transplant teams identify suitable donors for allogeneic stem cell transplantation. HLA markers help the immune system distinguish the body's cells from foreign cells. Doctors may first assess potentially suitable relatives. An unrelated donor search can follow when an appropriate family donor is unavailable. Turkey's Ministry of Health established TÜRKÖK in 2015 for national stem cell donor coordination. Ministry records also report its World Marrow Donor Association membership beginning in 2017. Turkish transplant centers document both domestic and overseas donor-search pathways. Registry participation does not guarantee that a suitable donor will be identified.

What Happens Before a Bone Marrow Transplant in Turkey?

Patients undergo detailed disease, organ, infection, and donor assessment before conditioning and stem cell infusion begin. Doctors review the diagnosis, disease status, previous therapies, medications, and relevant medical conditions. Blood testing evaluates counts and organ function. Heart and lung assessments may be required before intensive treatment. Allogeneic transplantation also requires detailed donor evaluation and compatibility testing. Conditioning usually involves chemotherapy and sometimes radiation therapy. Its intensity differs between transplant pathways and individual patients. Fertility preservation may also require discussion before treatment. The transplant team determines the final preparation plan after completing these clinical assessments.

What Is the Difference Between Engraftment and Immune Recovery?

Engraftment means new blood production has started, while complete immune recovery usually takes considerably longer. Doctors monitor blood counts after transplantation to follow new cell production. Increasing neutrophils provide an important sign of early hematopoietic recovery. Platelets and red blood cells can recover on different schedules. Normalizing blood counts does not mean immunity has fully returned. NCI notes immune recovery can take several months after autologous transplantation. It can take one to two years after allogeneic or syngeneic transplantation. This distinction explains why infection precautions and specialist follow-up can continue well beyond initial engraftment.

Which Complications Require Close Monitoring After Bone Marrow Transplant?

Bone marrow transplantation requires close monitoring because complications can affect immunity, blood production, organs, and donor-recipient interactions.

• Infection: Conditioning and immune suppression can temporarily increase vulnerability to bacterial, viral, and fungal infections.

• Graft-versus-host disease: Donor immune cells can attack healthy recipient tissues after allogeneic transplantation.

• Graft problems: Transplanted cells may establish blood production slowly or inadequately.

• Organ toxicity: Conditioning and transplant medicines can affect the liver, kidneys, lungs, heart, or other organs.

• Late effects: Some patients need longer-term monitoring for endocrine, fertility, bone, cardiovascular, or secondary cancer concerns.

Individual risks vary according to diagnosis, donor source, conditioning, previous treatment, and post-transplant medications.

Why Can Vaccination Be Needed Again After a Bone Marrow Transplant?

Revaccination can be necessary because stem cell transplantation can reduce protection created by vaccines received before treatment. Immune memory can change after conditioning and transplantation. CDC guidance therefore recommends revaccination after hematopoietic cell transplantation using vaccine-specific schedules. For example, Hib revaccination follows a new multi-dose schedule after successful transplantation. Timing depends on the vaccine, transplant pathway, immune status, and ongoing immunosuppressive treatment. Live vaccines require particularly careful specialist assessment. International patients should establish a written vaccination plan with their transplant team. Previous vaccination records alone cannot determine the complete post-transplant schedule.

What Should International Patients Verify Before Bone Marrow Transplantation in Turkey?

International patients should verify transplant eligibility, donor arrangements, provider authorization, records, and follow-up before traveling to Turkey. Complete records should include pathology, marrow findings, molecular results, previous treatments, and recent laboratory information. Potential donor information should also be provided when available. Turkey's Ministry of Health publishes healthcare providers authorized for international health-tourism services. Its current authorized-provider page is dated July 28, 2026. Authorization does not guarantee transplant suitability or treatment results. Patients should separately confirm the required transplant pathway. Post-discharge monitoring, emergency arrangements, medications, and communication with clinicians at home should also be established.

Bone Marrow Transplant in Turkey Cost 2026: What Affects the Total Cost?

Bone marrow transplant in Turkey has no single 2026 cost because clinical and donor requirements differ significantly between patients. This page therefore does not provide a fixed treatment price. Autologous and allogeneic transplantation require different resources. HLA testing, unrelated donor searches, stem cell collection, processing, and transport can influence costs. Conditioning medicines, hospitalization, blood products, laboratory monitoring, and supportive treatments also contribute. Complications can create additional requirements that cannot always be predicted before transplantation. International patients should request an individualized written quotation after medical assessment. The document should clearly identify included services, exclusions, donor-related expenses, and follow-up arrangements.

This content provides general medical information and does not recommend a transplant, healthcare provider, or clinical outcome. Bone marrow transplantation requires individualized assessment by appropriately qualified transplant professionals.

Last updated: August 14, 2026

Sources

• https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant

• https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/allogeneic

• https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/gvhd

• https://www.cdc.gov/vaccines/hcp/imz-best-practices/altered-immunocompetence.html

• https://www.cdc.gov/yellow-book/hcp/travelers-with-additional-considerations/immunocompromised-travelers.html

• https://www.saglik.gov.tr/EN-50747/1000th-and-1001st-transplants-at-turkok.html

• https://ankarasehir.saglik.gov.tr/EN-834597/adult-bone-marrow-center.html

• https://ankarasehir.saglik.gov.tr/EN-835041/pediatric-bone-marrow-center.html

• https://wmda.info/faq-about-stem-cell-donation/

• https://shgmturizmdb.saglik.gov.tr/EN-69061/authorized-healthcare-providers-and-facilitators.html

• https://shgmturizmdb.saglik.gov.tr/EN-108974/regulation-on-international-health-tourism-and-tourist-health.html

• https://antalyaism.saglik.gov.tr/TR-366500/saglik-hizmetlerinde-tanitim-ve-bilgilendirme--faaliyetleri-hakkinda-yonetmelik.html